MBM recognized as a Top 30 enterprise in the 2020 National Innovation & Entrepreneurship Competition
November 9, 2020
MBM’s “Artificial Intelligence Digital Pathology Analysis System for Tumor diagnostic” was unveiled in the finals of the Ninth China Innovation and Entrepreneurship Competition (CIEC) 2020 in Hangzhou on November 4-6.
The CIEC competition is regarded as the most prestigious and influential entrepreneurial competition in China, with the largest number of participating companies, attracting 35,788 companies this year.
At the opening ceremony, Mr. Jia Jingdun, director of the Torch Center of the Ministry of Science and Technology, said that the CIEC has created a way to effectively promote technological innovation and entrepreneurship under the guidance of the government, and encourages emerging companies to focus on national strategies, industrialization development, frontier technologies and healthcare.
MBM’s entry was based on our integrated AI digital pathology platform comprising an AI-compatible digital pathology scanner, AI image analysis software, supporting test kits and clinical pathology services lab. Mr. Zhu Weiyan, the founder and CEO of MBM, personally participated in the project presentation. In the end, MBM was ranked ninth in the cross-industry finals and won the “China Top 30 Innovation and Entrepreneurship Certificate”.